Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|June 10, 2009
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trialsNse Ntukidem, Carlos Arce-Lara, Gregory A Otterson, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 26, 2014
Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration dataRafael Santana-Davila, Aniko Szabo, Carlos Arce-Lara, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous TransplantationParameswaran Hari, Omar S Aljitawi, Carlos Arce-Lara, et al.Urology|June 19, 2007
Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approachCarlos Arce-Lara, Manisha H Shah, Rafael E Jimenez, et al.Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.Blood Cancer Journal|July 31, 2019
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myelomaBinod Dhakal, Anita D'Souza, Mehdi Hamadani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration dataRafael Santana-Davila, Kiran Devisetty, Aniko Szabo, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2014
Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosisBinod Dhakal, Christopher Strouse, Anita D'Souza, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2019
Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 TrialRichard F Ambinder, Juan Wu, Brent Logan, et al.Pageof 1